TDP-43 pathology in primary lateral sclerosis

References

• Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, et al. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91:373–7.
   PubMed Web of Science ®Google Scholar
• Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:133–45.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66:647–53.
   PubMed Web of Science ®Google Scholar
• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC, et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992;115:495–520.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61:427–34.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Ansorge O, Strong M, Bilbao J, Zinman L, Ang L-C, et al. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011;122:87–98.
   PubMed Web of Science ®Google Scholar
• Beal MF, Richardson EP Jr. Primary lateral sclerosis: a case report. Arch Neurol. 1981;38:630–3.
   PubMedGoogle Scholar
• Fisher CM. Pure spastic paralysis of corticospinal origin. Can J Neurol Sci. 1977;4:251–8.
   PubMed Web of Science ®Google Scholar
• Hirsch-Reinshagen V, Alfaify OA, Hsiung GYR, et al. Clinicopathologic correlations in a family with a TBK1 mutation presenting as primary progressive aphasia and primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:268–75.
   Web of Science ®Google Scholar
• Imai H, Furukawa Y, Sumino S, Mori H, Ueda G, Shirai T, et al. A 65-year-old woman with dysarthria, dysphagia, weakness, and gait disturbance. No To Shinkei. 1995;47:399–410.
   PubMedGoogle Scholar
• Koga H, Ozeki T, Makiura y, et al. Sporadic motor neuron disease with marked frontotemporal atrophy: an autopsied case mimicking primary lateral sclerosis. Neuropathology. 2003;23:A40.
   Google Scholar
• Konagaya M, Sakai M, Matsuoka Y, Konagaya Y, Hashizume Y. Upper motor neuron predominant degeneration with frontal and temporal lobe atrophy. Acta Neuropathol. 1998;96:532–6.
   PubMed Web of Science ®Google Scholar
• Kosaka T, Fu YJ, Shiga A, Ishidaira H, Tan CF, Tani T, et al. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration-immunohistochemical and biochemical analyses of TDP-43 . Neuropathology. 2012;32:373–84.
   PubMed Web of Science ®Google Scholar
• Kuzuhara S, Namura H, Inomasta H, et al. A case with marked atrophy in the frontotemporal lobe similar to Pick’s disease in addition to the clinical as well as pathological features of primary lateral sclerosis [in Japanese]. Shinkeibyouigaku Neuropathol. 1985;6:295–6.
   Google Scholar
• Lu JQ, Carter J, Johnston W. Primary lateral sclerosis without TDP-43 pathology: a case study. J Neuropathol Exp Neurol. 2010;69:533–4.
   Web of Science ®Google Scholar
• Mochizuki A, Komatsuzaki Y, Iwamoto H, Shoji S. Frontotemporal dementia with ubiquitinated neuronal inclusions presenting with primary lateral sclerosis and parkinsonism: clinicopathological report of an autopsy case. Acta Neuropathol. 2004;107:377–80.
   PubMed Web of Science ®Google Scholar
• Sugihara H, Horiuchi M, Kamo T, Fujisawa K, Abe M, Sakiyama T, et al. A case of primary lateral sclerosis taking a prolonged clinical course with dementia and having an unusual dendritic ballooning. Neuropathology. 1999;19:77–84.
   PubMed Web of Science ®Google Scholar
• Tan C-F, Kakita A, Piao Y-S, Kikugawa K, Endo K, Tanaka M, et al. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol. 2003;105:615–20.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Iino M, Honda M, Sano J, Hara M. Primary lateral sclerosis. Neuropathology. 1997;17:220–4.
   Web of Science ®Google Scholar
• Younger DS, Chou S, Hays AP, Lange DJ, Emerson R, Brin M, et al. Primary lateral sclerosis. A clinical diagnosis reemerges. Arch Neurol. 1988;45:1304–7.
   PubMedGoogle Scholar
• Dickson DW, Josephs KA, Amador-Ortiz C. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol. 2007;114:71–9.
   PubMed Web of Science ®Google Scholar
• Kobayashi Z, Tsuchiya K, Arai T, Yokota O, Yoshida M, Shimomura Y, et al. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss. J Neurol Sci. 2010;298:70–7.
   PubMed Web of Science ®Google Scholar
• Yokota O, Tsuchiya K, Arai T, Yagishita S, Matsubara O, Mochizuki A, et al. Clinicopathological characterization of Pick’s disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol. 2009;117:429–44.
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B, et al. Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol. 2013;126:537–44.
   PubMed Web of Science ®Google Scholar
• Hainfellner JA, Pilz P, Lassmann H, Ladurner G, Budka H. Diffuse Lewy body disease as substrate of primary lateral sclerosis. J Neurol. 1995;242:59–63.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Feldman H. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol. 2004;23:183–93.
   PubMed Web of Science ®Google Scholar
• Nagao S, Yokota O, Nanba R, Takata H, Haraguchi T, Ishizu H, et al. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. J Neurol Sci. 2012;323:147–53.
   PubMed Web of Science ®Google Scholar
• Godeiro-Junior C, Felicio AC, Benites V, Chieia MA, Oliveira ASB. Late-onset hexosaminidase A deficiency mimicking primary lateral sclerosis. Arq Neuropsiquiatr. 2009;67:105–6.
   PubMed Web of Science ®Google Scholar
• Hagiwara K, Murai H, Ochi H, Osoegawa M, Shigeto H, Ohyagi Y, et al. Upper motor neuron syndrome associated with subclinical Sjögren’s syndrome. Intern Med. 2008;47:1047–51.
   PubMed Web of Science ®Google Scholar
• Rowland LP. Paraneoplastic primary lateral sclerosis and amyotrophic lateral sclerosis. Ann Neurol. 1997;41:703–5.
   PubMed Web of Science ®Google Scholar
• Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM, et al. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett. 1988;93:197–203.
   PubMed Web of Science ®Google Scholar
• Lowe J, Lennox G, Jefferson D, Morrell K, McQuire D, Gray T, et al. A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett. 1988;94:203–10.
   PubMed Web of Science ®Google Scholar
• Gazulla J, Ferrer I, Izquierdo-Alvarez S, Alvarez S, Sánchez-Alcudia R, Bestué-Cardiel M, et al. Hereditary primary lateral sclerosis and progressive nonfluent aphasia. J Neurol. 2019;266:1079–90.
   PubMed Web of Science ®Google Scholar
• Gómez-Tortosa E, Van der Zee J, Ruggiero M, Gijselinck I, Esteban-Pérez J, García-Redondo A, et al.; EU EOD Consortium. Familial primary lateral sclerosis or dementia associated with Arg573Gly TBK1 mutation. J Neurol Neurosurg Psychiatry. 2017;88:996–7.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, van Blitterswijk M, Huisman MHB, Vlam L, van Doormaal PTC, Seelen M, et al. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology. 2012;79:878–2.
   PubMed Web of Science ®Google Scholar
• Kon T, Mori F, Oyama Y, Tanji K, Kimura T, Takahashi S, et al. An autopsy case of early-stage amyotrophic lateral sclerosis with TDP-43 immunoreactive neuronal, but not glial, inclusions. Neuropathology. 2019;39:224–30.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Hsiung G-YR, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on Chromosome 9p. Brain. 2012;135:709–22.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al.; ITALSGEN Consortium. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Stewart H, Rutherford NJ, Briemberg H, Krieger C, Cashman N, Fabros M, et al. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol. 2012;123:409–17.
   PubMed Web of Science ®Google Scholar